AR025389A1 - Indolinonas sustituidas, su preparacion y su empleo como medicamentos - Google Patents
Indolinonas sustituidas, su preparacion y su empleo como medicamentosInfo
- Publication number
- AR025389A1 AR025389A1 ARP000104413A ARP000104413A AR025389A1 AR 025389 A1 AR025389 A1 AR 025389A1 AR P000104413 A ARP000104413 A AR P000104413A AR P000104413 A ARP000104413 A AR P000104413A AR 025389 A1 AR025389 A1 AR 025389A1
- Authority
- AR
- Argentina
- Prior art keywords
- preparation
- indolinones
- medications
- employment
- replaced
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/622—Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/626—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B
- C04B35/63—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B using additives specially adapted for forming the products, e.g.. binder binders
- C04B35/632—Organic additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Ceramic Engineering (AREA)
- Manufacturing & Machinery (AREA)
- General Health & Medical Sciences (AREA)
- Inorganic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Structural Engineering (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials Engineering (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Abstract
La presente se refiere a indolinonas sustituidas de la formula general (1) en la que R1 a R6 y X están definidos como en la memoria descriptiva, a susisomeros y sus sales, en particular sus sales fisiologicamente compatibles, que presentan valiosasp ropiedades farmacologicas, en particular un efectoinhibidor sobre diferentes tirosinquinasas de receptor y complejos de ciclina/CDK, así como sobre la proliferacion de células endoteliales y diferentescélulas tumorales, a medicamentos quecontienen e stos compuestos, a su empleo y a procedimientos para su preparacion.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE1999140829 DE19940829A1 (de) | 1999-08-27 | 1999-08-27 | Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel |
DE2000129285 DE10029285A1 (de) | 2000-06-14 | 2000-06-14 | Neue substituierte Indolinone,ihre Herstellung und ihre Verwendung als Arzneimittel |
Publications (1)
Publication Number | Publication Date |
---|---|
AR025389A1 true AR025389A1 (es) | 2002-11-27 |
Family
ID=26006075
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP000104413A Pending AR025389A1 (es) | 1999-08-27 | 2000-08-25 | Indolinonas sustituidas, su preparacion y su empleo como medicamentos |
Country Status (12)
Country | Link |
---|---|
US (2) | US6794395B1 (es) |
EP (1) | EP1212318B1 (es) |
JP (1) | JP3952369B2 (es) |
AR (1) | AR025389A1 (es) |
AT (1) | ATE316527T1 (es) |
AU (1) | AU6998000A (es) |
CA (1) | CA2381821A1 (es) |
CO (1) | CO5180641A1 (es) |
DE (1) | DE50012136D1 (es) |
ES (1) | ES2257313T3 (es) |
MX (1) | MXPA02002097A (es) |
WO (1) | WO2001016130A1 (es) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10054019A1 (de) * | 2000-11-01 | 2002-05-23 | Boehringer Ingelheim Pharma | Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel |
US6638965B2 (en) | 2000-11-01 | 2003-10-28 | Boehringer Ingelheim Pharma Kg | Substituted indolinones, preparation thereof and their use as pharmaceutical compositions |
DE10117204A1 (de) | 2001-04-06 | 2002-10-10 | Boehringer Ingelheim Pharma | In 6-Stellung substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel |
EP1401413B1 (en) | 2001-06-29 | 2006-11-22 | AB Science | Use of tyrosine kinase inhibitions for treating allergic diseases |
ES2266553T3 (es) | 2001-06-29 | 2007-03-01 | Ab Science | Utilizacion de derivados de la n-fenil-2-pirimidina-amina para tratar las enfermedades inflamatorias. |
ES2274075T3 (es) | 2001-06-29 | 2007-05-16 | Ab Science | Utilizacion de inhibidores de c-kit para tratar enfermedades inflamatorias intestinales (eii). |
DE60223063T2 (de) | 2001-06-29 | 2008-07-17 | Ab Science | C-kit inhibitoren |
CA2461812C (en) * | 2001-09-27 | 2011-09-20 | Allergan, Inc. | 3-(arylamino)methylene-1,3-dihydro-2h-indol-2-ones as kinase inhibitors |
US6797825B2 (en) | 2001-12-13 | 2004-09-28 | Abbott Laboratories | Protein kinase inhibitors |
US20030187026A1 (en) | 2001-12-13 | 2003-10-02 | Qun Li | Kinase inhibitors |
US6686362B2 (en) | 2001-12-27 | 2004-02-03 | Theravance, Inc. | Indolinone derivatives |
US7514468B2 (en) | 2002-07-23 | 2009-04-07 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions |
US7169936B2 (en) | 2002-07-23 | 2007-01-30 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Indolinone derivatives substituted in the 6-position, their preparation and their use as medicaments |
US20040204458A1 (en) * | 2002-08-16 | 2004-10-14 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Use of Lck inhibitors for treatment of immunologic diseases |
US7148249B2 (en) * | 2002-09-12 | 2006-12-12 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Indolinones substituted by heterocycles, the preparation thereof and their use as medicaments |
JP4879492B2 (ja) * | 2002-11-27 | 2012-02-22 | アラーガン、インコーポレイテッド | 疾患の治療のためのキナーゼ阻害剤 |
US7799772B2 (en) * | 2003-12-18 | 2010-09-21 | Janssen Pharmaceutica N.V. | Pyrido-and pyrimidopyrimidine derivatives as anti-profilerative agents |
PE20060664A1 (es) * | 2004-09-15 | 2006-08-04 | Novartis Ag | Amidas biciclicas como inhibidores de cinasa |
NI200700147A (es) | 2004-12-08 | 2019-05-10 | Janssen Pharmaceutica Nv | Derivados de quinazolina inhibidores de cinasas dirigidos a multip |
JO3088B1 (ar) * | 2004-12-08 | 2017-03-15 | Janssen Pharmaceutica Nv | مشتقات كوينازولين كبيرة الحلقات و استعمالها بصفتها موانع كينيز متعددة الاهداف |
PE20060777A1 (es) | 2004-12-24 | 2006-10-06 | Boehringer Ingelheim Int | Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas |
EP1877376A1 (de) | 2005-04-28 | 2008-01-16 | Boehringer Ingelheim International GmbH | Neue verbindungen zur behandlung von entzündlichen erkrankungen |
CA2611401C (en) * | 2005-06-10 | 2014-02-11 | Merck Patent Gesellschaft Mit Beschraenkter Haftung | Oxindoles as kinase inhibitors |
GT200600411A (es) * | 2005-09-13 | 2007-05-21 | Novartis Ag | Combinaciones que comprenden un inhibidor del receptor del factor de crecimiento endotelial vascular |
WO2007122219A1 (en) * | 2006-04-24 | 2007-11-01 | Boehringer Ingelheim International Gmbh | 3- (aminomethyliden) 2-indolinone derivatives and their use as cell proliferation inhibitors |
JP2009542778A (ja) | 2006-07-13 | 2009-12-03 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | Mtkiキナゾリン誘導体 |
EP2167465A1 (en) * | 2007-06-12 | 2010-03-31 | Boehringer Ingelheim International GmbH | Indolinone derivatives and their use in treating disease-states such as cancer |
AU2008265104B2 (en) * | 2007-06-21 | 2013-09-12 | Janssen Pharmaceutica Nv | Indolin-2-ones and aza-indolin-2-ones |
JP5536647B2 (ja) | 2007-07-27 | 2014-07-02 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | ピロロピリミジン |
CA2731919A1 (en) * | 2008-07-29 | 2010-02-04 | Boehringer Ingelheim International Gmbh | New compounds |
WO2014086102A1 (zh) | 2012-12-06 | 2014-06-12 | 山东亨利医药科技有限责任公司 | 作为酪氨酸激酶抑制剂的吲哚满酮衍生物 |
WO2018160967A1 (en) * | 2017-03-02 | 2018-09-07 | Board Of Regents, The University Of Texas System | Indolinone derivatives as inhibitors of maternal embryonic leucine zipper kinase |
CN114181187A (zh) * | 2021-11-24 | 2022-03-15 | 上海应用技术大学 | 一种4-甲磺酰胺基丁酰胺化合物的制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9718913D0 (en) * | 1997-09-05 | 1997-11-12 | Glaxo Group Ltd | Substituted oxindole derivatives |
DE19815020A1 (de) | 1998-04-03 | 1999-10-07 | Boehringer Ingelheim Pharma | Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel |
DE19816624A1 (de) * | 1998-04-15 | 1999-10-21 | Boehringer Ingelheim Pharma | Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel |
-
2000
- 2000-08-22 JP JP2001519696A patent/JP3952369B2/ja not_active Expired - Fee Related
- 2000-08-22 MX MXPA02002097A patent/MXPA02002097A/es active IP Right Grant
- 2000-08-22 AU AU69980/00A patent/AU6998000A/en not_active Abandoned
- 2000-08-22 EP EP00958481A patent/EP1212318B1/de not_active Expired - Lifetime
- 2000-08-22 DE DE50012136T patent/DE50012136D1/de not_active Expired - Lifetime
- 2000-08-22 US US10/069,557 patent/US6794395B1/en not_active Expired - Lifetime
- 2000-08-22 AT AT00958481T patent/ATE316527T1/de not_active IP Right Cessation
- 2000-08-22 WO PCT/EP2000/008149 patent/WO2001016130A1/de active IP Right Grant
- 2000-08-22 CA CA002381821A patent/CA2381821A1/en not_active Abandoned
- 2000-08-22 ES ES00958481T patent/ES2257313T3/es not_active Expired - Lifetime
- 2000-08-25 AR ARP000104413A patent/AR025389A1/es active Pending
- 2000-08-25 CO CO00063885A patent/CO5180641A1/es not_active Application Discontinuation
-
2004
- 2004-07-27 US US10/900,162 patent/US20050009898A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20050009898A1 (en) | 2005-01-13 |
AU6998000A (en) | 2001-03-26 |
ES2257313T3 (es) | 2006-08-01 |
JP2003508394A (ja) | 2003-03-04 |
EP1212318B1 (de) | 2006-01-25 |
MXPA02002097A (es) | 2002-11-07 |
ATE316527T1 (de) | 2006-02-15 |
DE50012136D1 (en) | 2006-04-13 |
US6794395B1 (en) | 2004-09-21 |
CA2381821A1 (en) | 2001-03-08 |
EP1212318A1 (de) | 2002-06-12 |
CO5180641A1 (es) | 2002-07-30 |
WO2001016130A1 (de) | 2001-03-08 |
JP3952369B2 (ja) | 2007-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR025389A1 (es) | Indolinonas sustituidas, su preparacion y su empleo como medicamentos | |
AR026036A1 (es) | Indolinonas sustituidas en posicion 6, su preparacion y su utilizacion como medicamentos | |
TR200002980T2 (tr) | İnhibe edici etkiye sahip ikame edilmiş indolinonlar | |
ES2196860T3 (es) | Nuevas indolinonas sustituidas con efecto inhibidor sobre diferentes cinasas y diferentes complejos ciclina/cdk. | |
AR026037A1 (es) | Indolinonas sustituidas en posicion 5, su preparacion y su utilizacion como medicamentos | |
AR027113A1 (es) | Piperidinas sustiutidas, medicamentos que contienen estos compuestos y procedimiento par su preparacion | |
TR200003515T2 (tr) | İkame edilmiş indolinon, bunların imalatı ve ilaç olarak kullanımı | |
UY26066A1 (es) | Heterociclos biciclicos, medicamentos que contienen estos compuestos, su empleo y procedimientos para su preparacion | |
BR9911017A (pt) | Derivados de indol e seu emprego para o tratamento de doenças malignas e outras, que se baseiam na proliferação de células patológicas | |
AR024345A1 (es) | Derivados de purina | |
BR0010716A (pt) | Compostos de fenila substituìdos com atividade imunossupressora e composições farmacêuticas | |
BRPI0517921A (pt) | métodos para preparar compostos de indazol | |
CO5180590A1 (es) | Derivados de camptotecina que tienen actividad anti tumores | |
UY26659A1 (es) | Heterociclos bicíclicos, medicamentos que contienen estos compuestos, su empleo y procedimientos para su preparación | |
ECSP034776A (es) | Indolinonas sustituidas en posicion 6, su preparacion y su utilizacion como medicamentos | |
PT1242060E (pt) | Tratamento da doenca metastatica | |
GT200300294A (es) | Compuestos de indazol y composiciones farmaceuticas para inhibir proteinquinasas y procedimientos para su uso | |
BRPI0410632A (pt) | piridopirazinas e uso das mesmas como inibidores de cinase | |
ES2192877T3 (es) | 4-alquenil (y alquinil) oxindoles como inhibidores de kinasas ciclina-dependientes, en particular cdk2. | |
UY27903A1 (es) | Derivados de indolinona sustituidos en posición 6, su preparación y su uso como medicamentos. | |
BR0112807A (pt) | Derivados de indol e sua aplicação como medicamento | |
UY26988A1 (es) | Nuevas indolinonas sustituidas, su preparación y su utilización como medicamentos. | |
UY26308A1 (es) | Nuevas indolinonas sustituidas, su preparación y su empleo como medicamentos | |
PT1305041E (pt) | Medicamento para a imunoterapia de tumores malignos | |
ECSP003710A (es) | Indolinonas sustituidas en posicion 6, su preparacion y su utilizacion como medicamentos |